Singapore markets close in 2 hours
  • Straits Times Index

    3,139.79
    +10.02 (+0.32%)
     
  • Nikkei

    28,725.47
    -135.15 (-0.47%)
     
  • Hang Seng

    24,236.92
    +240.05 (+1.00%)
     
  • FTSE 100

    7,337.05
    -2.85 (-0.04%)
     
  • BTC-USD

    49,684.60
    -1,023.31 (-2.02%)
     
  • CMC Crypto 200

    1,301.50
    -3.62 (-0.28%)
     
  • S&P 500

    4,701.21
    +14.46 (+0.31%)
     
  • Dow

    35,754.75
    +35.32 (+0.10%)
     
  • Nasdaq

    15,786.99
    +100.07 (+0.64%)
     
  • Gold

    1,785.90
    +0.40 (+0.02%)
     
  • Crude Oil

    73.00
    +0.64 (+0.88%)
     
  • 10-Yr Bond

    1.5090
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,497.76
    +3.73 (+0.25%)
     
  • Jakarta Composite Index

    6,619.60
    +15.81 (+0.24%)
     
  • PSE Index

    7,217.05
    +69.75 (+0.98%)
     

Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results

  • Oops!
    Something went wrong.
    Please try again later.
·8-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Fiscal 2021 revenue increased 12% year-over-year to $46.5 million

Software revenue increased 28% year-over-year to $27.7 million

Fiscal 2022 financial outlook for total revenue of $51 million to $53 million, reflecting 10% to 15% year-over-year growth

LANCASTER, Calif., October 25, 2021--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today reported financial results for its fourth quarter and full year 2021 fiscal year, ended August 31, 2021.

"We finished the year in a better position than we anticipated following our third quarter earnings report driven by both strong GastroPlus® sales and continued momentum in ADMET Predictor® sales following the introduction of new product functionality," said Shawn O’Connor, chief executive officer. "We also benefitted from our consulting services business returning to more normalized operations with an increasing backlog and improved pipeline of new opportunities, furthering our belief that the events of the third quarter were a short-term occurrence, and the business remains fundamentally healthy."

Fourth Quarter Financial Highlights (compared with the corresponding period last fiscal year):

  • Total revenue increased 3% to $9.8 million

  • Software revenue increased 14% to $5.4 million, representing 55% of total revenue

  • Services revenue declined 7% to $4.4 million, representing 45% of total revenue

  • Gross profit increased 3% to $7.1 million

  • Gross margin was unchanged at 72%

  • Net income was $0.3 million compared to $2.2 million for the period last fiscal year

  • Diluted earnings per share was $0.01 compared to $0.11 for the period last fiscal year

Full Year Financial Highlights (compared with the corresponding period last fiscal year):

  • Total revenue increased 12% to $46.5 million

  • Software revenue increased 28% to $27.7 million, representing 60% of total revenue

  • Services revenue declined 6% to $18.8 million, representing 40% of total revenue

  • Gross profit increased 16% to $35.9 million

  • Gross margin increased from 74% to 77%

  • Net income was $9.8 million compared to $9.3 million for the period last fiscal year

  • Diluted earnings per share was $0.47 compared to $0.50 for the period last fiscal year

Fiscal 2022 Financial Outlook

The Company expects full year fiscal 2022 total revenue to be in the range of $51 million to $53 million, representing 10% to 15% year-over-year growth.

Software revenue is expected to be in the range of 55% to 60% of total revenue and services revenue is expected to be in the range of 40% to 45% of total revenue. Services revenue is expected to recover sequentially throughout fiscal 2022 and any acquisitions would be incremental to the revenue growth target above.

Mr. O’Connor concluded, "We believe our proven business model and increasing software revenue mix will enable us to grow our bottom line faster than our top line, while generating strong cash flows to further strengthen our balance sheet. Our already strong balance sheet reduces the need to secure additional capital as we’re evaluating strategic acquisition opportunities that we believe can further position us for success and support our revenue CAGR target above 20% as we’ve achieved since our Cognigen acquisition in fiscal 2015."

Quarterly Dividend Declared

On October 13, 2021, the Company’s Board of Directors declared a cash dividend of $0.06 per share of the Company’s common stock, payable on November 1, 2021, to shareholders of record as of October 25, 2021. The declaration of any future dividends will be determined by the Board of Directors each quarter and will depend on earnings, financial condition, capital requirements, and other factors.

Investor Conference Call

The Company will host a conference call on October 25, 2021, at 5 p.m. Eastern Time. All interested parties are invited to join the call by registering here or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be available on the Investors page of the Simulations Plus website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call.

About Simulations Plus, Inc.

Serving clients worldwide for 25 years, Simulations Plus, Inc. is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 – With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Words like "believe," "expect" and "anticipate" mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission.

SIMULATIONS PLUS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

Three months ended August 31,

Years ended August 31,

(in thousands, except per common share amounts)

2021

2020

2021

2020

(Unaudited)

(Unaudited)

Revenues

$

9,841

$

9,540

$

46,466

$

41,589

Cost of revenues

2,785

$

2,675

10,600

10,649

Gross profit

7,056

$

6,865

35,866

30,940

Operating expenses

Research and development

1,277

948

4,047

2,975

Selling, general and administrative

5,606

3,713

20,566

16,360

Total operating expenses

6,883

4,661

24,613

19,335

Income from operations

173

2,204

11,253

11,605

Other income (expense)

Interest income

46

2

201

30

Interest expense

(22

)

Change in value of contingent consideration

(122

)

(122

)

(486

)

(203

)

Gain (loss) on currency exchange

78

(46

)

139

(45

)

Total other income (expense), net

2

(166

)

(168

)

(218

)

Income before income taxes

175

2,038

11,085

11,387

Provision for income taxes

130

150

(1,303

)

(2,055

)

Net Income

$

305

$

2,188

$

9,782

$

9,332

Earnings per share

Basic

$

0.02

$

0.12

$

0.49

$

0.52

Diluted

$

0.01

$

0.11

$

0.47

$

0.50

Weighted-average common shares outstanding

Basic

20,137

18,289

20,045

17,819

Diluted

20,753

19,152

20,743

18,538

Other comprehensive income (loss), net of tax

Foreign currency translation adjustments

(137

)

28

(101

)

58

Comprehensive income

$

168

$

2,216

$

9,681

$

9,390

SIMULATIONS PLUS, INC.

CONSOLIDATED BALANCE SHEETS

August 31,

(In thousands, except share and per share amounts)

2021

2020

ASSETS

Current assets

Cash and cash equivalents

$

36,984

$

49,207

Accounts receivable, net of allowance for doubtful accounts of $78 and $50

9,851

7,422

Revenues in excess of billings

3,150

3,093

Prepaid income taxes

1,012

970

Prepaid expenses and other current assets

1,696

1,596

Short-term investments

86,620

66,804

Total current assets

139,313

129,092

Long-term assets

Capitalized computer software development costs,

net of accumulated amortization of $14,438 and $13,582

7,646

6,087

Property and equipment, net

1,838

438

Operating lease right of use asset

1,276

927

Intellectual property, net of accumulated amortization of $6,516 and $5,087

10,469

11,898

Other intangible assets, net of accumulated amortization of $2,186 and $1,642

6,464

7,008

Goodwill

12,921

12,921

Other assets

51

51

Total assets

$

179,978

$

168,422

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities

Accounts payable

$

387

$

351

Accrued payroll and other expenses

5,604

2,251

Contracts payable - current portion

4,550

2,000

Billings in excess of revenues

117

141

Operating lease liability, current portion

382

463

Deferred revenue

534

300

Total current liabilities

11,574

5,506

Long-term liabilities

Deferred income taxes, net

1,726

2,354

Operating lease liability

896

463

Contracts payable - net of current portion

4,064

Total liabilities

14,196

12,387

Commitments and contingencies

-

-

Shareholders' equity

Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding

$

-

$

-

Common stock, $0.001 par value and additional paid-in capital — 50,000,000 shares

authorized, 20,141,521 and 19,923,277 shares issued and outstanding

133,418

128,541

Retained earnings

32,407

27,436

Accumulated other comprehensive income (loss)

(43

)

58

Total shareholders' equity

165,782

156,035

Total liabilities and shareholders' equity

$

179,978

$

168,422

View source version on businesswire.com: https://www.businesswire.com/news/home/20211025005732/en/

Contacts

Simulations Plus Investor Relations
Ms. Renee Bouche
661-723-7723
renee.bouche@simulations-plus.com

Hayden IR
Mr. Brian Siegel
346-396-8696
brian@haydenir.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting